vs

Side-by-side financial comparison of BayFirst Financial Corp. (BAFN) and KORU Medical Systems, Inc. (KRMD). Click either name above to swap in a different company.

KORU Medical Systems, Inc. is the larger business by last-quarter revenue ($10.9M vs $10.3M, roughly 1.1× BayFirst Financial Corp.). Over the past eight quarters, KORU Medical Systems, Inc.'s revenue compounded faster (15.3% CAGR vs -29.6%).

The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.

KORU Medical Systems, Inc. is a specialized medical technology company that designs, manufactures, and distributes innovative ambulatory infusion systems and supporting disposable products. It caters to healthcare providers and patients across home care, clinical trial, and acute care segments worldwide, with a focus on enhancing the safety and comfort of specialty medication delivery.

BAFN vs KRMD — Head-to-Head

Bigger by revenue
KRMD
KRMD
1.1× larger
KRMD
$10.9M
$10.3M
BAFN
Faster 2-yr revenue CAGR
KRMD
KRMD
Annualised
KRMD
15.3%
-29.6%
BAFN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BAFN
BAFN
KRMD
KRMD
Revenue
$10.3M
$10.9M
Net Profit
$-5.7M
Gross Margin
62.6%
Operating Margin
-5.0%
Net Margin
-55.0%
Revenue YoY
23.3%
Net Profit YoY
-130.6%
EPS (diluted)
$-1.48
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAFN
BAFN
KRMD
KRMD
Q1 26
$10.3M
Q4 25
$11.2M
$10.9M
Q3 25
$10.2M
$10.4M
Q2 25
$23.1M
$10.2M
Q1 25
$19.8M
$9.6M
Q4 24
$32.9M
$8.8M
Q3 24
$21.7M
$8.2M
Q2 24
$20.8M
$8.4M
Net Profit
BAFN
BAFN
KRMD
KRMD
Q1 26
$-5.7M
Q4 25
$-2.5M
Q3 25
$-18.9M
$-778.0K
Q2 25
$-1.2M
$-206.9K
Q1 25
$-335.0K
$-1.2M
Q4 24
$9.8M
Q3 24
$1.1M
$-1.6M
Q2 24
$866.0K
$-988.7K
Gross Margin
BAFN
BAFN
KRMD
KRMD
Q1 26
Q4 25
62.6%
Q3 25
60.2%
Q2 25
63.5%
Q1 25
62.8%
Q4 24
62.9%
Q3 24
63.4%
Q2 24
65.0%
Operating Margin
BAFN
BAFN
KRMD
KRMD
Q1 26
Q4 25
-25.3%
-5.0%
Q3 25
-253.0%
-8.3%
Q2 25
-7.1%
-3.1%
Q1 25
-2.3%
-12.9%
Q4 24
-18.0%
Q3 24
7.1%
-20.8%
Q2 24
5.9%
-14.1%
Net Margin
BAFN
BAFN
KRMD
KRMD
Q1 26
-55.0%
Q4 25
-22.1%
Q3 25
-184.7%
-7.5%
Q2 25
-5.3%
-2.0%
Q1 25
-1.7%
-12.1%
Q4 24
91.8%
Q3 24
5.2%
-19.3%
Q2 24
4.2%
-11.7%
EPS (diluted)
BAFN
BAFN
KRMD
KRMD
Q1 26
$-1.48
Q4 25
$-0.71
$-0.11
Q3 25
$-4.66
$0.02
Q2 25
$-0.39
$0.00
Q1 25
$-0.17
$0.03
Q4 24
$2.21
$-0.22
Q3 24
$0.18
$0.03
Q2 24
$0.12
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAFN
BAFN
KRMD
KRMD
Cash + ST InvestmentsLiquidity on hand
$134.5M
$8.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$81.9M
$17.0M
Total Assets
$1.2B
$28.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAFN
BAFN
KRMD
KRMD
Q1 26
$134.5M
Q4 25
$207.0M
$8.9M
Q3 25
$118.5M
$8.5M
Q2 25
$77.3M
$8.1M
Q1 25
$63.2M
$8.7M
Q4 24
$77.8M
$9.6M
Q3 24
$64.4M
$8.8M
Q2 24
$60.8M
$10.5M
Stockholders' Equity
BAFN
BAFN
KRMD
KRMD
Q1 26
$81.9M
Q4 25
$87.6M
$17.0M
Q3 25
$89.7M
$16.5M
Q2 25
$108.2M
$16.5M
Q1 25
$110.1M
$16.3M
Q4 24
$110.9M
$16.8M
Q3 24
$102.3M
$17.7M
Q2 24
$101.0M
$18.7M
Total Assets
BAFN
BAFN
KRMD
KRMD
Q1 26
$1.2B
Q4 25
$1.3B
$28.2M
Q3 25
$1.3B
$27.1M
Q2 25
$1.3B
$25.5M
Q1 25
$1.3B
$27.2M
Q4 24
$1.3B
$27.2M
Q3 24
$1.2B
$27.4M
Q2 24
$1.2B
$27.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAFN
BAFN
KRMD
KRMD
Operating Cash FlowLast quarter
$1.1M
Free Cash FlowOCF − Capex
$687.0K
FCF MarginFCF / Revenue
6.3%
Capex IntensityCapex / Revenue
3.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-470.1K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAFN
BAFN
KRMD
KRMD
Q1 26
Q4 25
$285.3M
$1.1M
Q3 25
$47.3M
$65.5K
Q2 25
$63.3M
$-460.3K
Q1 25
$74.2M
$-237.5K
Q4 24
$390.5M
$939.6K
Q3 24
$90.8M
$-923.9K
Q2 24
$78.8M
$11.3K
Free Cash Flow
BAFN
BAFN
KRMD
KRMD
Q1 26
Q4 25
$285.0M
$687.0K
Q3 25
$47.3M
$13.0K
Q2 25
$63.1M
$-489.2K
Q1 25
$74.1M
$-680.9K
Q4 24
$388.8M
$896.0K
Q3 24
$90.5M
$-2.0M
Q2 24
$78.4M
$-112.9K
FCF Margin
BAFN
BAFN
KRMD
KRMD
Q1 26
Q4 25
2554.2%
6.3%
Q3 25
462.2%
0.1%
Q2 25
272.7%
-4.8%
Q1 25
375.1%
-7.1%
Q4 24
1180.9%
10.1%
Q3 24
416.5%
-24.5%
Q2 24
376.1%
-1.3%
Capex Intensity
BAFN
BAFN
KRMD
KRMD
Q1 26
Q4 25
2.7%
3.7%
Q3 25
0.1%
0.5%
Q2 25
0.8%
0.3%
Q1 25
0.4%
4.6%
Q4 24
5.1%
0.5%
Q3 24
1.5%
13.2%
Q2 24
1.9%
1.5%
Cash Conversion
BAFN
BAFN
KRMD
KRMD
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
39.95×
Q3 24
79.85×
Q2 24
90.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BAFN
BAFN

Net Interest Income$9.4M91%
Noninterest Income$884.0K9%

KRMD
KRMD

US$8.3M76%
Non Us$2.6M24%

Related Comparisons